Evidence map›Paper›PMID 42045277›Full record

ArticleNPJ vaccines2026

Preclinical efficacy of dendritic cells loaded with newly identified HPV11 E6-derived CD8

Laurie Baert, Chao Gu, Agnes Yang, HyeMee Joo, Richard Kennedy, Kieth Knutson, David G Lott, SangKon Oh

Abstract read
In one paragraph

Article in NPJ vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laurie Baert *Department of Immunology, Mayo Clinic, Scottsdale, AZ, USA.
Chao Gu *Department of Immunology, Mayo Clinic, Scottsdale, AZ, USA.
Agnes YangDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, USA.
HyeMee JooDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, USA.
Richard KennedyDepartment of Immunology, Mayo Clinic, Rochester, MN, USA.
Kieth KnutsonDepartment of Immunology, Mayo Clinic, Jacksonville, FL, USA.
David G LottDepartment of Otolaryngology-Head & Neck Surgery/Audiology, Mayo Clinic, Phoenix, AZ, USA.
SangKon OhDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, USA. Oh.SangKon@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the low-risk human papillomaviruses (HPVs), including HPV11, are mainly associated with low-grade lesions, they are also implicated in otolaryngologic malignancies and lung carcinomas. Nonetheless, T cell responses to the low-risk HPVs remain poorly understood. This study investigated HPV11 E6/7-specific T cell responses in C57BL/6 mice challenged with TC-1 tumor cells expressing HPV11 E6/7 proteins (TC-1.HPV11 E6/7). We identified two major CD8

Identifiers

PMID42045277
PMCPMC13324742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.